USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS
The present disclosure provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient in need a BET (bromodomain and extra-terminal protein) inhibitor, or a pharmaceutically acceptable salt thereof, alone or in combination with one or more JAK inhibitors. Also provided are medicaments for use in treating cancer..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 01. Sept. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ARONCHIK IDA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-09-01, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08 |
|---|
| Patentnummer: |
CA3206708 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017904161 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017904161 | ||
| 003 | DE-627 | ||
| 005 | 20240308102051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230915s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017904161 | ||
| 035 | |a (EPA)CA3206708 | ||
| 035 | |a (EPA)80786345 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ARONCHIK IDA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a USE OF A BET INHIBITOR ALONE OR IN COMBINATION WITH FEDRATINIB OR RUXOLITINIB FOR TREATING A HEMATOLOGICAL MALIGNANCY SUCH AS MYELOFIBROSIS |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-09-01, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08 | ||
| 520 | |a The present disclosure provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient in need a BET (bromodomain and extra-terminal protein) inhibitor, or a pharmaceutically acceptable salt thereof, alone or in combination with one or more JAK inhibitors. Also provided are medicaments for use in treating cancer. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BELTRAN VALENCIA ROXXANA VALERIA |4 aut | |
| 700 | 0 | |a CARRANCIO ANTON MARIA SORAYA |4 aut | |
| 700 | 0 | |a CHANG HENRY H |4 aut | |
| 700 | 0 | |a COKER SHODEINDE |4 aut | |
| 700 | 0 | |a DAS SHARMILA |4 aut | |
| 700 | 0 | |a FILVAROFF ELLEN HOPE |4 aut | |
| 700 | 0 | |a GUARINOS MARHUENDA CARLA |4 aut | |
| 700 | 0 | |a HANNA BISHOY |4 aut | |
| 700 | 0 | |a LIU YU |4 aut | |
| 700 | 0 | |a NIKOLOVA ZARIANA |4 aut | |
| 700 | 0 | |a ESPOSITO ORIANA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 01. Sept. |
| 773 | 1 | 8 | |g year:2022 |g day:01 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/80786345/publication/CA3206708A1?q=CA3206708 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 01 |c 09 | ||